Find a TenderPast planning notice
Published 11 Feb 2021, 22:56 GMT

Official UK procurement notice

Enhanced Chemical Analysis for Copper Sulphate

Official notice

Authority: NHS Blood and Transplant (Central government)

6 lotsServicesMax 6 lots per supplier
Sectors: Architecture & Engineering (71) Delivery: UK
Planned pipeline valueValue not publishedpipeline notice, not a live tender
Tender notice expected 17 Mar 2021from the planned procurement notice
Lots 6max 6 won per supplier

What is being bought6 lots · detail below

Published requirement description

NHSBT are seeking an enhanced analysis of Copper Sulphate solution which is an in vitro, semi-quantitative reagent used for investigation on the acceptance of blood donor minimum haemoglobin levels when taken from a capillary blood sample. The reagent is used to test a droplet of blood from a donor’s finger, following the use of a lancet, which will be transferred into the solution using a pipette.

NHSBT must update the product conformity profile for this device and must understand the impact when exposed to different variables throughout its formulation process, transportation, use and storage. The profile is to be produced through a number of studies for visual, chemical and therapeutic analysis. In current practice, NHSBT Copper Sulphate solutions are used professionally for male and female specific testing to ensure only suitable donors are bled. Therefore, all studies must be conducted for scenario 1) Female Donation and Scenario 2) Male Donation.

CPV: Laboratory services

Lots and requirements (6)Procurement structure

6 lots · no lot values published · win at most 6 of them
Lot #1Study 1 - Assessment of products useful lifePlanned

Study 1 - Assessment of products useful life

This is to be determined through the maximum number of drops of blood that can be added to the copper sulphate before the product returns an inaccurate result under varying conditions.

Delivery: UK
Lot #2Study 2 - Assessment of the device’s stability during shelf lifePlanned

Study 2 - Assessment of the device’s stability during shelf life

During routine storage at what point does the device start to fail:

(a) Visually

(i) Photostability storage study

(ii) Integrity of the labels when exposed to routine use, light.

(b) Chemically

(i) Chemical analysis storage study

(ii)Theoretical analysis of formula to outline potential chemical interactions that may degrade over time.

Delivery: UK
Lot #3Study 3 - Bacterial contaminationPlanned

Study 3 - Bacterial contamination

(a) During routine storage, at what point does bacterial ingress occur – Bacterial storage study to be conducted on fresh and end of shelf life product.

(b) If the product is challenged with routine environmental microbiological contaminants does this result in proliferation of the contaminants? - Controlled bacterial challenge study conducted on fresh and end of shelf life product.

Delivery: UK
Lot #4Study 4 – PackagingPlanned

Study 4 – Packaging

Study to challenge the packaging to address the impact and potential for:

(a) Product leakage

(b) Product damage – Physical and degradation of the bottles and or seal

(c) Product evaporation

(d) Electrostatic impacts (from packaging material)

Delivery: UK
Lot #5Study 5 – Health and SafetyPlanned

Study 5 – Health and Safety

Health and safety evaluation in accordance with Directive:

(a) Risk to individuals

(b) Appropriate method of discard

(c) Shipping and Transportation recommendations

Delivery: UK
Lot #6Study 6 – Impacts to Specific GravityPlanned

Study 6 – Impacts to Specific Gravity

Assessment of the impact of temperature on the specific gravity of the device:

(a) Theoretical analysis of the device to calculate in the potential changes in Specific gravity that could occur under routine storage conditions

(b) Study protocol to test the male and female device for specific gravity under a range of routine storage temperatures and in use parameters

Delivery: UK

Procedure terms & legal framework

From the official record
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Past planning notice
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
11 Feb 2021, 22:56 GMT
Last source update
11 Feb 2021, 22:56 GMT
Authority reference
NHSBT1491
FTS notice number
2021/S 000-002850
Classification (CPV)
Laboratory services
Delivery area
UK
Official registry OCID
ocds-h6vhtk-029289 Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

11 Feb 2021 → 17 Mar 2021 · 2 dates
  1. Notice published
    11 Feb 2021, 22:56 GMT
  2. Tender notice expected
    17 Mar 2021

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Blood & Transplant

Contracting authorityCentral GovernmentBody governed by public lawHealth North Bristol Park, Filton, Bristol, UK, BS34 7QHContact email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.